Lonza’s sales statement came fully out of the blue and it looks to us as if the company wanted to clear up some uncertainties as the CEO’s position is still vacant. The reported growth rates at CC were still good, especially in the speciality chemicals business, but a comparison in absolute figures is not possible as the company has provided only the relative development in the past.
17 Apr 2020
Will pharma's resilience be bullet-proof?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Will pharma's resilience be bullet-proof?
Lonza Group AG (0QNO:LON) | 0 0 0.0% | Mkt Cap: 22,735m
- Published:
17 Apr 2020 -
Author:
Martin Schnee -
Pages:
2
Lonza’s sales statement came fully out of the blue and it looks to us as if the company wanted to clear up some uncertainties as the CEO’s position is still vacant. The reported growth rates at CC were still good, especially in the speciality chemicals business, but a comparison in absolute figures is not possible as the company has provided only the relative development in the past.